NCT06685809View on ClinicalTrials.gov

A Phase 1 Study of FZ008-145 in Healthy Subjects.

PHASE1RecruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

November 26, 2025

Study Completion Date

December 26, 2025

Conditions
Healthy
Interventions
DRUG

FZ008-145 solution

Dose formulation- Oral solution

DRUG

FZ008-145 Tablet

Dose formulation- Oral tablet

DRUG

Placebo

Dose formulation- Matching doses

DRUG

FZ008-145 Tablet and Placebo

Dose formulation- Oral tablet

DRUG

FZ008-145 Tablet and Placebo

Dose formulation- Oral tablet

Trial Locations (1)

5000

RECRUITING

CMAX Clinical Research Pty, Adelaide

All Listed Sponsors
lead

Guangzhou Fermion Technology Co., LTD

INDUSTRY